http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02295925-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21cfb7dd79973529725cde19b4f43cba |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 1990-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02f483293ccdde2b1936b56a211ba08c |
| publicationDate | 1990-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H02295925-A |
| titleOfInvention | Ophthalmic drug composition for topical administration having improved topical resistance |
| abstract | PURPOSE: To obtain the subject composition containing bendazac, 5-OH bendazac and a specific amount of free lysine and enabling continuous administration over a long period. n CONSTITUTION: This ophthalmic drug composition for topical administration having improved topical resistance contains an active component selected from bendazac, 5-OH bendazac and its physiologically permissible organic or inorganic base salt (preferably lysine salt or arginine salt) and 0.1-3mol, especially 0.5-2mol, of free lysine based on 1mol of the active component. An example of the composition is an aseptic aqueous solution containing 0.5wt.% of bendazac lysinate, 0.188wt.% of free lysine, 0.38wt.% of boric acid, 0.81wt.% of potassium chloride and 0.5wt.% of hydroxypropyl methylcellulose. n COPYRIGHT: (C)1990,JPO |
| priorityDate | 1989-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.